The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.

Completed · Not applicable

Conditions studied: Nuclear Sclerosis of the Lens, Posterior Subcapsular Cataract, Cortical Cataract

In brief

This study compares two FDA approved Cataract Lasers.

Key facts

Study ID

NCT01878838

Run by

Steven H. Linn, OD

People needed

45

Starts

2013-04-01

Expected to finish

2014-01-01

Last updated by the study team

2025-03-11

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have grade 2 to 4 nuclear sclerotic and or cortical or posterior subcapsular cataracts with visual impairment.
• Pupillary dilation of at least 6.0 mm
• Axial length between 21 mm to 26 mm
• Age ≥ 22 years of either gender
• Require laser assisted corneal incisions, capsulotomy and nucleus segmentation
• Understand and sign a written Informed Consent form
• Be able to comply with the treatment and follow-up schedule

You may not qualify if…

• Enrolment in another drug or device study within the prior 3 months
• History of ocular trauma
• Acute or chronic disease or illness that would increase risk or confound study results (e.g., uncontrolled diabetes mellitus, immunocompromised, etc.)
• Uncontrolled systemic or ocular disease
• Corneal abnormalities (e.g., stromal, epithelial or endothelial dystrophies, severe corneal opacities, significant corneal edema, etc)
• Diminished aqueous clarity that obscures OCT imaging of the anterior lens capsule
• Corneal ring and/or inlay implant(s)
• Pseudoexfoliation
• Known steroid IOP responder or ocular hypertension IOP >25 mmHg by tonometry
• Retinal detachment within the last 6 months
• Anterior chamber depth less than 2.5 mm

Where it is running

• Hoopes Vision — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.